ONLINE DATABASE SEARCH - OI-LS-298-MEMO
1. 43569 OI-LS-298; EMBASE-OI-6/16/2004
Synthesis, absolute stereochemistry and molecular design of the new antifungal and antibacterial antibiotic produced by Streptomyces sp.201
Boruwa, J, Kalita, B, Barua, NC, Borah, JC, Mazumder, S, Thakur, D, Gogoi, DK, and Bora, TC
Bioorganic & Medicinal Chemistry Letters 2004. 14(13): 3571-3574
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CDHFTG-1/2/89df9c7e5129e56c8809cfdbf8395451
2. 43570 OI-LS-298; EMBASE-OI-6/16/2004
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans
Blasi, Elisabetta, Colombari, Bruna, Francesca Orsi, Carlotta, Pinti, Marcello, Leonarda Troiano, Cossarizza, Andrea, Esposito, Roberto, Peppoloni, Samuela, Mussini, Cristina, and Neglia, Rachele
FEMS Immunology and Medical Microbiology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2T-4CFV437-1/2/b73559b04110f8f95e4af2b0b6ec6aa9
3. 43571 OI-LS-298; EMBASE-OI-6/16/2004
Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray
Wade, Mary Margaret, Volokhov, Dmitriy, Peredelchuk, Mike, Chizhikov, Vladimir, and Zhang, Ying
Diagnostic Microbiology and Infectious Disease 2004. 49(2): 89-97
HYPERLINK: http://www.sciencedirect.com/science/article/B6T60-4CJC1NP-5/2/9a8113e6dfd39d1a08446af63d2cd2b3
4. 43572 OI-LS-298; PUBMED-OI-6/16/2004
Non-nucleoside inhibitors of the HCV polymerase
Sarisky, RT
J Antimicrob Chemother 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15190019&dopt=abstract
5. 43573 OI-LS-298; EMBASE-OI-6/16/2004
Microarrays for Mycobacterium tuberculosis
Butcher, Philip D
Tuberculosis 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WXK-4C7DD0F-1/2/a0861a97748b697448cf93a409a99d1a
6. 43574 OI-LS-298; PUBMED-OI-6/16/2004
(+)-Bornyl Piperate, a New Monoterpene Ester from Piper aff. pedicellatum Roots
Rukachaisirikul, T, Prabpai, S, Kongsaeree, P, and Suksamrarn, A
Chem Pharm Bull (Tokyo) 2004. 52(6): 760-1
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15187402&dopt=abstract
7. 43575 OI-LS-298; PUBMED-OI-6/16/2004
Number of Drugs to Treat Multidrug-resistant Tuberculosis
Seung, KJ, Joseph, K, Hurtado, R, Rich, M, Shin, S, Furin, J, Leandre, F, Mukherjee, J, Farmer, P, and Caminero, JA
Am J Respir Crit Care Med 2004. 169(12): 1336-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15187016&dopt=abstract
8. 43576 OI-LS-298; PUBMED-OI-6/16/2004
Differential expression of mycothiol pathway genes: are they affected by antituberculosis drugs?
Hayward, D, Wiid, I, and van Helden, P
IUBMB Life 2004. 56(3): 131-138
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15185746&dopt=abstract
9. 43577 OI-LS-298; PUBMED-OI-6/16/2004
Molecular Characterization of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Strains Isolated in Poland
Sajduda, A, Brzostek, A, Poplawska, M, Augustynowicz-Kopec, E, Zwolska, Z, Niemann, S, Dziadek, J, and Hillemann, D
J Clin Microbiol 2004. 42(6): 2425-31
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15184414&dopt=abstract
10. 43578 OI-LS-298; PUBMED-OI-6/16/2004
Direct fluorometric measurement of hepatitis C virus helicase activity
Boguszewska-Chachulska, AM, Krawczyk, M, Stankiewicz, A, Gozdek, A, Haenni, AL, and Strokovskaya, L
FEBS Lett 2004. 567(2-3): 253-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15178332&dopt=abstract
11. 43579 OI-LS-298; PUBMED-OI-6/16/2004
Synthesis and in vitro antifungal activity of 4-substituted phenylguanidinium salts
Braunerova, G, Buchta, V, Silva, L, Kunes, J, and Palat, K Jr
Farmaco 2004. 59(6): 443-50
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15178306&dopt=abstract
12. 43580 OI-LS-298; PUBMED-OI-6/16/2004
(1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases
Frederickson, M, Roszak, AW, Coggins, JR, Lapthorn, AJ, and Abell, C
Org Biomol Chem 2004. 2(11): 1592-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15162210&dopt=abstract
13. 43581 OI-LS-298; EMBASE-OI-6/16/2004
Synthesis of a bromotyrosine-derived natural product inhibitor of mycothiol-S-conjugate amidase
Fetterolf, Brandon and Bewley, Carole A
Bioorganic & Medicinal Chemistry Letters 2004. 14(14): 3785-3788
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CGM744-3/2/22b750d323e43b88ac4d34f2e0d7c667
14. 43582 OI-LS-298; EMBASE-OI-6/16/2004
Amidine derived 1,3-diazabuta-1,3-dienes as potential antibacterial and antifungal agents
Bedi, Preet MS, Mahajan, Mohinder P, and Kapoor, Vijay K
Bioorganic & Medicinal Chemistry Letters 2004. 14(14): 3821-3824
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CGM744-6/2/57e131828f3db6af23d6fca8bf1939f0
15. 43583 OI-LS-298; EMBASE-OI-6/16/2004
Thiourea inhibitors of herpes viruses. Part 2: N-Benzyl-N'-arylthiourea inhibitors of CMV
Bloom, Jonathan D, Dushin, Russell G, Curran, Kevin J, Donahue, Fran, Norton, Emily B, Terefenko, Eugene, Jones, Thomas R, Ross, Adma A, Feld, Boris, Lang, Stanley A, and DiGrandi, Martin J
Bioorganic & Medicinal Chemistry Letters 2004. 14(13): 3401-3406
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CF5BWW-3/2/467e728a1d403c41ee898db05b90a2c0
16. 43584 OI-LS-298; PUBMED-OI-6/16/2004
Pneumocystis activates human alveolar macrophage NF-kappaB signaling through mannose receptors
Zhang, J, Zhu, J, Imrich, A, Cushion, M, Kinane, TB, and Koziel, H
Infect Immun 2004. 72(6): 3147-60
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15155616&dopt=abstract
17. 43585 OI-LS-298; EMBASE-OI-6/16/2004
Caspofungin: the first licensed antifungal drug of the novel echinocandin class
DiNubile, Mark J, Motyl, Mary, and Sable, Carole A
Clinical Microbiology Newsletter 2004. 26(11): 81-85
HYPERLINK: http://www.sciencedirect.com/science/article/B6T5D-4CG91SN-1/2/34404ca49623bc5aa947c74e61f2f861
18. 43586 OI-LS-298; PUBMED-OI-6/16/2004
Effects of voriconazole on Cryptococcus neoformans
van Duin, D, Cleare, W, Zaragoza, O, Casadevall, A, and Nosanchuk, JD
Antimicrob Agents Chemother 2004. 48(6): 2014-2020
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15155193&dopt=abstract
19. 43587 OI-LS-298; EMBASE-OI-6/16/2004
Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778
Evers, David L, Wang, Xin, Huong, Shu-Mei, Andreoni, Kenneth A, and Huang, Eng-Shang
Antiviral Research 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4CGNBJ8-1/2/d49270fba8e338682b914b690533edbf
20. 43588 OI-LS-298; EMBASE-OI-6/16/2004
3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling
Evers, David L, Wang, Xin, Huong, Shu-Mei, Huang, David Y, and Huang, Eng-Shang
Antiviral Research 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4CFV465-1/2/fbf7ee156d6b30960d1472d3d194c56b
21. 43589 OI-LS-298; PUBMED-OI-6/16/2004
Synthesis, antimicrobial activity and chemotherapeutic potential of inorganic derivatives of 2-(4(')-thiazolyl)benzimidazole{thiabendazole}: X-ray crystal structures of [Cu(TBZH)(2)Cl]Cl [Formula: see text] H(2)O [Formula: see text] EtOH and TBZH(2)NO(3) (TBZH=thiabendazole)
Devereux, M, McCann, M, O, Shea D, Kelly, R, Egan, D, Deegan, C, Kavanagh, K, McKee, V, and Finn, G
J Inorg Biochem 2004. 98(6): 1023-1031
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15149811&dopt=abstract
22. 43590 OI-LS-298; WOS-OI-6/6/2004
Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro
Kaur, S and Singh, PP
SCAND J IMMUNOL 2004. 59(5): 425-431
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221306400002
23. 43591 OI-LS-298; EMBASE-OI-6/16/2004
Antiviral therapies
Hallenberger, Sabine
Journal of Clinical Virology 2004. 30(Supplement 1): S22-S24
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJV-4C009SK-3/2/edb1fc49cf7d309cb99e7149556cd145
24. 43592 OI-LS-298; EMBASE-OI-6/16/2004
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization
Perni, Robert B, Pitlik, Janos, Britt, Shawn D, Court, John J, Courtney, Lawrence F, Deininger, David D, Farmer, Luc J, Gates, Cynthia A, Harbeson, Scott L, and Levin, Rhonda B
Bioorganic & Medicinal Chemistry Letters 2004. 14(6): 1441-1446
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BT8F6G-H/2/9bbd356c0a66e302e25d91dffc807e19
25. 43593 OI-LS-298; WOS-OI-6/6/2004
Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms
Fortune, SM, Solache, A, Jaeger, A, Hill, PJ, Belisle, JT, Bloom, BR, Rubin, EJ, and Ernst, JD
J IMMUNOL 2004. 172(10): 6272-6280
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221276900061
26. 43594 OI-LS-298; WOS-OI-6/6/2004
Safety, pharmacokinetics and pharmacodynamic results of higher doses of albuferon in a phase 1/2 single and double dose-escalation study in treatment experienced subjects with chronic hepatitis C
Balan, V, Sulkowski, M, Nelson, D, Everson, G, Dickson, R, Lambiase, L, Post, A, Redfield, R, Wiesner, R, Recta, J, Osborn, B, Novello, L, Freimuth, W, and Subramanian, M
J HEPATOL 2004. 40: 135
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220950800457
27. 43595 OI-LS-298; EMBASE-OI-6/16/2004
522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS(R)) plus ribavirin (COPEGUS(R)) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)
Weiland, O, Fried, MW, Hadziyannis, SJ, Foster, GR, Messinger, D, Freivogel, K, and Chaneac, M
Journal of Hepatology 2004. 40(Supplement 1): 154
HYPERLINK: http://www.sciencedirect.com/science/article/B6W7C-4C5WW3G-MN/2/cd9c3203b9eb388223e5b118e5630a88
28. 43596 OI-LS-298; EMBASE-OI-6/16/2004
Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase
Jain, Rajendra P and Vederas, John C
Bioorganic & Medicinal Chemistry Letters 2004. 14(14): 3655-3658
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4CJCTNH-5/2/c6c63ca22a4656bcc0bd877278362e4c
29. 43597 OI-LS-298; EMBASE-OI-6/16/2004
Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo
Beljaars, Leonie, van der Strate, Barry WA, Bakker, Hester I, Reker-Smit, Catharina, van Loenen-Weemaes, Anne-miek, Wiegmans, Frouwke C, Harmsen, Martin C, Molema, Grietje, and Meijer, Dirk KF
Antiviral Research 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4CMHXVJ-1/2/21c251602e63142df90009d4b73c39d8
30. 43598 OI-LS-298; WOS-OI-6/6/2004
Biochemical and genetic analysis of the four DNA ligases of mycobacteria
Gong, CL, Martins, A, Bongiorno, P, Glickman, M, and Shuman, S
J BIOL CHEM 2004. 279(20): 20594-20606
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221273800008
31. 43599 OI-LS-298; WOS-OI-6/6/2004
Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system
Bourne, N, Pyles, R, Yi, MK, Veselenak, R, Davis, M, and Lemon, S
ANTIVIR RES 2004. 62(2): A50
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800060
32. 43600 OI-LS-298; WOS-OI-6/6/2004
In vitro combination studies of VX-950 (a HCV protease inhibitor) or VX-497 (an IMPDH inhibitor), two novel anti-HCV clinical candidates, with IFN-alpha
Lin, K, Lin, C, and Kwong, AD
ANTIVIR RES 2004. 62(2): A52
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800065
33. 43601 OI-LS-298; WOS-OI-6/6/2004
Antiviral activity of Glycyrrhizic Acid (GL) derivatives against SARS-coronavirus (SARS-CoV) and human cytomegalovirus (HCMV)
Hoever, G, Baltina, L, Kondratenko, R, Baltina, L, Tolstikov, G, Doerr, HW, and Cinatl, J
ANTIVIR RES 2004. 62(2): A75
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800121
34. 43602 OI-LS-298; WOS-OI-6/6/2004
Inhibition of hepatitis C virus RNA replication by benzimidazoles with high affinity for the 5 '-untranslated region of the genomic RNA
Swayze, EE, Seth, P, Jefferson, EA, Miyaji, A, Osgood, S, Ranken, R, Propp, S, Lowery, K, and Griffey, RH
ANTIVIR RES 2004. 62(2): A82
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800142
35. 43603 OI-LS-298; WOS-OI-6/6/2004
In vitro and in vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection
Ilan, E, Zauberman, A, Aviel, S, Nussbaum, O, Arazi, E, Ben-Moshe, O, Slama, D, Tzionas, I, Shoshany, Y, Lee, SW, Han, JJ, Park, SJ, Lee, GH, Park, EY, Shin, JC, Suh, JW, Kim, JW, and Dagan, S
ANTIVIR RES 2004. 62(2): A83
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221142800144
36. 43604 OI-LS-298; WOS-OI-6/13/2004
A semi-empirical study of biflavonoid compounds with biological activity against tuberculosis
Dias, JC, Rebelo, MM, and Alves, CN
J MOL STRUC-THEOCHEM 2004. 676(1-3): 83-87
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221351100013
37. 43605 OI-LS-298; WOS-OI-6/13/2004
Antibacterial and antifugal mono- and di-substituted symmetrical and unsymmetrical triazine-derived Schiff-bases and their transition metal complexes
Chohan, ZH, Pervez, H, Rauf, A, Khan, KM, Maharvi, GM, and Supuran, CT
J ENZYM INHIB MED CH 2004. 19(2): 161-168
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221450100009
38. 43606 OI-LS-298; WOS-OI-6/13/2004
Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria
Mehta, R, Pearson, JT, Mahajan, S, Nath, A, Hickey, MJ, Sherman, DR, and Atkins, WM
J BIOL CHEM 2004. 279(21): 22477-22482
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221417100097
39. 43607 OI-LS-298; WOS-OI-6/13/2004
Application of high throughput technologies to drug substance and drug product development
Gardner, CR, Almarsson, O, Chen, HM, Morissette, S, Peterson, M, Zhang, Z, Wang, S, Lemmo, A, Gonzalez-Zugasti, J, Monagle, J, Marchionna, J, Ellis, S, McNulty, C, Johnson, A, Levinson, D, and Cima, M
COMPUT CHEM ENG 2004. 28(6-7): 943-953
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221418000008
40. 43608 OI-LS-298; WOS-OI-6/13/2004
Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria
McGarvey, JA, Wagner, D, and Bermudez, LE
CLIN EXP IMMUNOL 2004. 136(3): 490-500
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000221420700013